Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ConjuChem initiates U.S. trial for DAC:GLP-1

May 13, 2003

Lilly scientists identify phenanthrene-based LXR activators

May 13, 2003

FDA approves new flexible dosing regimen for Lantus

May 13, 2003

Novel H3 receptor modulators designed by Novo Nordisk and Boehringer Ingelheim team

May 12, 2003

Emisphere's oral insulin candidate enters clinical testing

May 12, 2003

Orphan drug application filed for IoGen

May 9, 2003

GSK scientists prepare and test new cathepsin K inhibitors

May 9, 2003

Additional data analyses submitted in Mexico for Sucanon

May 9, 2003

CytRx expands RNAi collaboration with Massachusetts medical school

May 7, 2003

Japanese rights to NBI-6024 returned to Neurocrine

May 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...